Sun Pharmaceutical Industries said that it has entered into a global exclusive commercialization, license, and supply agreement with Philogen for commercializing the latter’s specialty product Fibromun.
Subscribe To Our Free Newsletter |
Sun Pharmaceutical Industries said that it has entered into a global exclusive commercialization, license, and supply agreement with Philogen for commercializing the latter’s specialty product Fibromun.
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!